Predictive biomarkers play a crucial role in personalized medicine, enabling the tailoring of therapeutic strategies to individual patients. By identifying which patients are likely to benefit from a particular treatment, clinicians can make informed decisions, thereby improving treatment outcomes and minimizing potential side effects. For example, the presence of HER2 overexpression in breast cancer patients can predict responsiveness to targeted therapies such as trastuzumab.
